Integrated Filing — IndAS

General information about company

Scrip Code	542650
NSE Symbol	METROPOLIS
MSEI Symbol	NOTLISTED
ISIN	INE112L01020
Name of company	Metropolis Healthcare Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-04-2025
Date of end of financial year	31-03-2026
Date of board meeting when results were approved	13-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	07-05-2026
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Pathology Services
Start date and time of board meeting	13-05-2026 14:16:00
End date and time of board meeting	13-05-2026 17:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS

Amount in (Lakhs)

Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2026	01-04-2025
B	Date of end of reporting period	31-03-2026	31-03-2026
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
1	Income
	Revenue from operations	42,468.16	1,64,584.59
	Other income	816.15	2,558.44
	Total income	43,284.31	1,67,143.03
2	Expenses
(a)	Cost of materials consumed	7,848.18	32,451.66
(b)	Purchases of stock-in-trade	0.00	0.00
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0.00	0.00
(d)	Employee benefit expense	9,546.74	37,736.48
(e)	Finance costs	793.29	2,454.38
(f)	Depreciation, depletion and amortisation expense	3,859.04	13,372.15
(f)	Other Expenses
1	Laboratory testing charges	430.66	2,300.49
2	Others	13,840.83	52,011.35
	Total other expenses	14,271.49	54,311.84
	Total expenses	36,318.74	1,40,326.51
3	Total profit before exceptional items and tax	6,965.57	26,816.52
4	Exceptional items	10.69	(898.96)
5	Total profit before tax	6,976.26	25,917.56
6	Tax expense
7	Current tax	2,247.41	7,369.17
8	Deferred tax	(367.10)	(569.81)
9	Total tax expenses	1,880.31	6,799.36
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0.00	0.00
11	Net Profit Loss for the period from continuing operations	5,095.95	19,118.20
12	Profit (loss) from discontinued operations before tax	0.00	0.00
13	Tax expense of discontinued operations	0.00	0.00
14	Net profit (loss) from discontinued operation after tax	0.00	0.00
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0.00	0.00
16	Total profit (loss) for period	5,095.95	19,118.20
17	Other comprehensive income net of taxes	335.38	481.95
18	Total Comprehensive Income for the period	5,431.33	19,600.15
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	5,090.301	19,001.745
	Total profit or loss, attributable to non-controlling interests	5.648	116.47
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	334.681	481.684
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0.699	0.266
21	Details of equity share capital
	Paid-up equity share capital	4,146.57	4,146.57
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		1,47,169.49
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	2.46	9.19
	Diluted earnings (loss) per share from continuing operations	2.46	9.19
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	2.46	9.19
	Diluted earnings (loss) per share from continuing and discontinued operations	2.46	9.19
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Textual Information(1)

Disclosure of notes on financial results

Textual Information(1)	Refer the financial results pdf uploaded on stock exchange for the full notes

Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2025
Date of end of reporting period		31-03-2026
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	21,529.89
	Capital work-in-progress	0.00
	Investment property	0.00
	Goodwill	66,024.91
	Other intangible assets	53,083.03
	Intangible assets under development	0.00
	Biological assets other than bearer plants	0.00
	Investments accounted for using equity method	19,471.51
	Non-current financial assets
	Non-current investments	175.28
	Trade receivables, non-current	0.00
	Loans, non-current	0.00
	Other non-current financial assets
1	Other non-current financial assets	2,055.12
	Total of other non-current financial assets	2,055.12
	Total non-current financial assets	2,230.40
	Deferred tax assets (net)	716.59
	Other non-current assets
1	Non-current tax assets (Net)	3,356.39
2	Other non-current assets	531.53
	Total of other non-current assets	3,887.92
	Total non-current assets	1,66,944.25
2	Current assets
	Inventories	4,549.37
	Current financial asset
	Current investments	14,064.59
	Trade receivables, current	17,028.53
	Cash and cash equivalents	5,478.36
	Bank balance other than cash and cash equivalents	753.49
	Loans, current	0.00
	Other current financial assets
	Total of other current financial assets	1,268.08
	Total current financial assets	38,593.05
	Current tax assets (net)
	Other current assets
1	Other current assets	3,718.78
	Total of other current assets	3,718.78
	Total current assets	46,861.20
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	2,13,805.45
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	4,146.57
	Other equity	1,47,169.49
	Total equity attributable to owners of parent	1,51,316.06
	Non controlling interest	1,139.44
	Total equity	1,52,455.50
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0.00
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities
1	Lease Liabilities	13,826.55
2	Other financial liabilities	142.78
	Total of other non-current financial liabilities	13,969.33
	Total non-current financial liabilities	13,969.33
	Provisions, non-current	3,415.76
	Deferred tax liabilities (net)	10,562.66
	Deferred government grants, Non-current
	Other non-current liabilities
	Total of other non-current liabilities
	Total non-current liabilities	27,947.75
	Current liabilities
	Current financial liabilities
	Borrowings, current	1,873.07
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	721.28
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	12,220.59
	Total Trade payable	12,941.87
	Other current financial liabilities
1	Lease Liabilities	7,491.48
2	Other financial liabilities	2,338.92
	Total of other current financial liabilities	9,830.40
	Total current financial liabilities	24,645.34
	Other current liabilities	2,700.86
1	Other current liabilities	2,700.86
	Total of other current liabilities	2,700.86
	Provisions, current	1,423.79
	Current tax liabilities (Net)	4,632.21
	Deferred government grants, Current
	Total current liabilities	33,402.20
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	61,349.95
	Total equity and liabilites	2,13,805.45
	Disclosure of notes on assets and liabilities	Textual Information(1)

Text Block

Textual Information(1)	Refer the financial results pdf uploaded on stock exchange for the full notes

Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-01-2026	01-04-2025
Date of end of reporting period		31-03-2026	31-03-2026
Whether results are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income

Amount in (Lakhs)

Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2026	01-04-2025
B	Date of end of reporting period	31-03-2026	31-03-2026
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified subsequently to profit and loss	52.92	43.79
	Total Amount of items that will not be reclassified to profit and loss	52.92	43.79
2	Income tax relating to items that will not be reclassified to profit or loss	15.74	2.80
3	Amount of items that will be reclassified to profit and loss
1	Items that will be subsequently reclassified to profit and loss	0.00	0.00
	Total Amount of items that will be reclassified to profit and loss	0.00	0.00
4	Income tax relating to items that will be reclassified to profit or loss	(298.20)	(440.96)
5	Total Other comprehensive income	335.38	481.95

Cash flow statement, indirect

Amount in (Lakhs)

Particulars			Year ended (dd-mm-yyyy)
A	Date of start of reporting period		01-04-2025
B	Date of end of reporting period		31-03-2026
C	Whether results are audited or unaudited		Audited
D	Nature of report standalone or consolidated		Consolidated
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax		25,917.56
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs		0.00
	Adjustments for decrease (increase) in inventories		0.00
	Adjustments for decrease (increase) in trade receivables, current		(4,896.80)
	Adjustments for decrease (increase) in trade receivables, non-current		0.00
	Adjustments for decrease (increase) in other current assets		323.18
	Adjustments for decrease (increase) in other non-current assets		(1,262.76)
	Adjustments for other financial assets, non-current		(176.33)
	Adjustments for other financial assets, current		87.04
	Adjustments for other bank balances		0.00
	Adjustments for increase (decrease) in trade payables, current		(228.03)
	Adjustments for increase (decrease) in trade payables, non-current		0.00
	Adjustments for increase (decrease) in other current liabilities		105.35
	Adjustments for increase (decrease) in other non-current liabilities		0.00
	Adjustments for depreciation and amortisation expense		13,372.15
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss		0.00
	Adjustments for provisions, current		2,579.97
	Adjustments for provisions, non-current		423.13
	Adjustments for other financial liabilities, current		2,209.99
	Adjustments for other financial liabilities, non-current		390.52
	Adjustments for unrealised foreign exchange losses gains		(506.24)
	Adjustments for dividend income		0.00
	Adjustments for interest income		0.00
	Adjustments for share-based payments		807.39
	Adjustments for fair value losses (gains)		0.00
	Adjustments for undistributed profits of associates		0.00
	Other adjustments for which cash effects are investing or financing cash flow		(64.82)
	Other adjustments to reconcile profit (loss)		(1.06)
	Other adjustments for non-cash items		618.84
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships		0.00
	Total adjustments for reconcile profit (loss)		13,781.52
	Net cash flows from (used in) operations		39,699.08
	Dividends received		0.00
	Interest paid		(231.80)
	Interest received		(239.76)
	Income taxes paid (refund)		4,659.21
	Other inflows (outflows) of cash		37.61
	Net cash flows from (used in) operating activities		35,069.52
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses		0.00
	Cash flows used in obtaining control of subsidiaries or other businesses		0.00
	Other cash receipts from sales of equity or debt instruments of other entities		0.00
	Other cash payments to acquire equity or debt instruments of other entities		0.00
	Other cash receipts from sales of interests in joint ventures		0.00
	Other cash payments to acquire interests in joint ventures		0.00
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships		0.00
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships		0.00
	Proceeds from sales of property, plant and equipment		(26.97)
	Purchase of property, plant and equipment		4,348.89
	Proceeds from sales of investment property		0.00
	Purchase of investment property		11,341.43
	Proceeds from sales of intangible assets		0.00
	Purchase of intangible assets		(769.47)
	Proceeds from sales of intangible assets under development		0.00
	Purchase of intangible assets under development		0.00
	Proceeds from sales of goodwill		0.00
	Purchase of goodwill		0.00
	Proceeds from biological assets other than bearer plants		0.00
	Purchase of biological assets other than bearer plants		0.00
	Proceeds from government grants		0.00
	Proceeds from sales of other long-term assets		34,833.03
	Purchase of other long-term assets		41,127.21
	Cash advances and loans made to other parties		0.00
	Cash receipts from repayment of advances and loans made to other parties		0.00
	Cash payments for future contracts, forward contracts, option contracts and swap contracts		0.00
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts		0.00
	Dividends received		0.00
	Interest received		172.52
	Income taxes paid (refund)		0.00
	Other inflows (outflows) of cash		(1,243.02)
	Net cash flows from (used in) investing activities	(22,312.50)
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries		0.00
	Payments from changes in ownership interests in subsidiaries		0.00
	Proceeds from issuing shares		0.00
	Proceeds from issuing other equity instruments		0.00
	Payments to acquire or redeem entity's shares		(656.01)
	Payments of other equity instruments		0.00
	Proceeds from exercise of stock options		0.65
	Proceeds from issuing debentures notes bonds etc		0.00
	Proceeds from borrowings		0.00
	Repayments of borrowings		0.00
	Payments of lease liabilities		8,126.59
	Dividends paid		2,072.88
	Interest paid		2,440.34
	Income taxes paid (refund)		0.00
	Other inflows (outflows) of cash		453.68
	Net cash flows from (used in) financing activities		(11,529.47)
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes		1,227.55
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents		303.25
	Net increase (decrease) in cash and cash equivalents		1,530.80
	Cash and cash equivalents cash flow statement at beginning of period		3,947.56
	Cash and cash equivalents cash flow statement at end of period		5,478.36

Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited	Audited
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results	No

Sr No.	Audit firm's name	Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI	Certificate valid upto
1	B S R & Co. LLP	Yes	31-07-2028